Adrenal cortex ontogenesis

Best Practice and Research: Clinical Endocrinology and Metabolism

Volumn 24, Issue 6, 2010, Pages 853-864

  Lalli, Enzo ^a,b  

^a INSTITUT DE PHARMACOLOGIE MOLÉCULAIRE ET CELLULAIRE   (France)

^b UNIVERSITÉ CÔTE D'AZUR   (France)

Author keywords

Adrenal gland; Development; Signalling; Transcription factors

Indexed keywords

ALDOSTERONE; BETA CATENIN; CITED2 PROTEIN; CORTICOTROPIN; M33 PROTEIN; NUCLEAR RECEPTOR DAX 1; PROOPIOMELANOCORTIN; PROTEIN; SONIC HEDGEHOG PROTEIN; STEROIDOGENIC FACTOR 1; TESTOSTERONE; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR PBX1; UNCLASSIFIED DRUG; WNT4 PROTEIN; WT1 PROTEIN;

ADRENAL CORTEX; ADRENAL CORTEX TUMOR; ALLGROVE SYNDROME; CONGENITAL DISORDER; DEVELOPMENT; EMBRYO DEVELOPMENT; HUMAN; LOSS OF FUNCTION MUTATION; NONHUMAN; PRIMORDIUM; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; REVIEW; SIGNAL TRANSDUCTION; STEROIDOGENESIS;

ADRENAL CORTEX; ADRENAL CORTEX DISEASES; ADRENAL CORTEX NEOPLASMS; ANIMALS; HUMANS; MOLECULAR TARGETED THERAPY; ORGANOGENESIS;

EID: 78649657062     PISSN: 1521690X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.beem.2010.10.009     Document Type: Review

References (100)

1. P.M. Stewart The adrenal cortex P.R. Larsen, H.M. Kronenberg, S. Melmed, K.S. Polonsky, Williams Textbook of Endocrinology 10th edn 2003 Saunders Philadelphia 491 551
2. O. Hatano, A. Takakusu, and M. Nomura Identical origin of adrenal cortex and gonad revealed by expression profiles of Ad4BP/SF-1 Genes to Cells 1 1996 663 671
3. C.E. Keegan, and G.D. Hammer Recent insights into organogenesis of the adrenal cortex Trends in Endocrinology and Metabolism 13 2002 200 208
4. C. Wotus, B.K. Levay-Young, and L.M. Rogers Development of adrenal zonation in fetal rats defined by expression of aldosterone synthase and 11beta-hydroxylase Endocrinology 139 1998 4397 4403
5. L. Hershkovitz, F. Beuschlein, and S. Klammer Adrenal 20alpha-hydroxysteroid dehydrogenase in the mouse catabolizes progesterone and 11-deoxycorticosterone and is restricted to the X-zone Endocrinology 148 2007 976 988
6. S. Tanaka, and A. Matsuzawa Comparison of adrenocortical zonation in C57BL/6J and DDD mice Experimental Animals 44 1995 285 291
7. S. Mesiano, and R.B. Jaffe Developmental and functional biology of the primate fetal adrenal cortex Endocrine Reviews 18 1997 378 403 (Pubitemid 27246882)
8. G.J. Pepe, and E.D. Albrecht Regulation of the primate fetal adrenal cortex Endocrine Reviews 11 1990 151 176
9. S.J. Spencer, S. Mesiano, and J.Y. Lee Proliferation and apoptosis in the human adrenal cortex during the fetal and perinatal periods: implications for growth and remodeling The Journal of Clinical Endocrinology and Metabolism 84 1999 1110 1115
10. S. Ben-David, N. Zuckerman-Levin, and M. Epelman Parturition itself is the basis for fetal adrenal involution The Journal of Clinical Endocrinology and Metabolism 92 2007 93 97
11. D.A. Haber, A.J. Buckler, and T. Glaser An internal deletion within an 11p13 zinc finger gene contributes to the development of Wilms' tumor Cell 61 1990 1257 1269
12. J.A. Kreidberg, H. Sariola, and J.M. Loring WT-1 is required for early kidney development Cell 74 1993 679 691
13. A.W. Moore, L. McInnes, and J. Kreidberg YAC complementation shows a requirement for Wt1 in the development of epicardium, adrenal gland and throughout nephrogenesis Development 126 1999 1845 1857
14. V. Vidal, and A. Schedl Requirement of WT1 for gonad and adrenal development: insights from transgenic animals Endocrine Research 26 2000 1075 1082
15. S. Bhattacharya, C.L. Michels, and M.K. Leung Functional role of p35srj, a novel p300/CBP binding protein, during transactivation by HIF-1 Genes & Development 13 1999 64 75
16. S.D. Bamforth, J. Bragana, and J.J. Eloranta Cardiac malformations, adrenal agenesis, neural crest defects and exencephaly in mice lacking Cited2, a new Tfap2 co-activator Nature Genetics 29 2001 469 474
17. J. Bragana, T. Swingler, and F.I. Marques Human CREB-binding protein/p300-interacting transactivator with ED-rich tail (CITED) 4, a new member of the CITED family, functions as a co-activator for transcription factor AP-2 The Journal of Biological Chemistry 277 2002 8559 8565
18. E.S. Tien, J.W. Davis, and J.P. Vanden Heuvel Identification of the CREB-binding protein/p300-interacting protein CITED2 as a peroxisome proliferator-activated receptor alpha coregulator The Journal of Biological Chemistry 279 2004 24053 24063
19. P. Val, J.P. Martinez-Barbera, and A. Swain Adrenal development is initiated by Cited2 and Wt1 through modulation of Sf-1 dosage Development 134 2007 2349 2358
20. B. Ferraz-de-Souza, F. Martin, and D. Mallet CBP/p300-interacting transactivator, with Glu/Asp-rich C-terminal domain, 2, and pre-B-cell leukemia transcription factor 1 in human adrenal development and disease The Journal of Clinical Endocrinology and Metabolism 94 2009 678 683
21. Y. Katoh-Fukui, A. Owaki, and Y. Toyama Mouse Polycomb M33 is required for splenic vascular and adrenal gland formation through regulating Ad4BP/SF1 expression Blood 106 2005 1612 1620
22. R. van Amerongen, and R. Nusse Towards an integrated view of Wnt signaling in development Development 136 2009 3205 3214
23. S. Vainio, M. Heikkilä, and A. Kispert Female development in mammals is regulated by Wnt-4 signalling Nature 397 1999 405 409
24. B.K. Jordan, J.H. Shen, and R. Olaso Wnt4 overexpression disrupts normal testicular vasculature and inhibits testosterone synthesis by repressing steroidogenic factor 1/beta-catenin synergy Proceedings of the National Academy of Sciences of the United States of America 100 2003 10866 10871
25. M. Heikkilä, H. Peltoketo, and J. Leppäluoto Wnt-4 deficiency alters mouse adrenal cortex function, reducing aldosterone production Endocrinology 143 2002 4358 4365
26. B.K. Jordan, M. Mohammed, and S.T. Ching Up-regulation of WNT-4 signaling and dosage-sensitive sex reversal in humans American Journal of Human Genetics 68 2001 1102 1109
27. A. Biason-Lauber, D. Konrad, and F. Navratil A WNT4 mutation associated with Müllerian-duct regression and virilization in a 46, XX woman The New England Journal of Medicine 351 2004 792 798
28. A. Biason-Lauber, G. De Filippo, and D. Konrad WNT4 deficiency-a clinical phenotype distinct from the classic Mayer-Rokitansky-Kuster-Hauser syndrome: a case report Human Reproduction 22 2007 224 229
29. P. Philibert, A. Biason-Lauber, and R. Rouzier Identification and functional analysis of a new WNT4 gene mutation among 28 adolescent girls with primary amenorrhea and müllerian duct abnormalities: a French collaborative study The Journal of Clinical Endocrinology and Metabolism 93 2008 895 900
30. T.R. Bürglin Analysis of TALE superclass homeobox genes (MEIS, PBC, KNOX, Iroquois, TGIF) reveals a novel domain conserved between plants and animals Nucleic Acids Research 25 1997 4173 4180
31. Y. Jacobs, C.A. Schnabel, and M.L. Cleary Trimeric association of Hox and TALE homeodomain proteins mediates Hoxb2 hindbrain enhancer activity Molecular and Cellular Biology 19 1999 5134 5142
32. C.A. Schnabel, L. Selleri, and M.L. Cleary Pbx1 is essential for adrenal development and urogenital differentiation Genesis 37 2003 123 130
33. M. Zubair, S. Ishihara, and S. Oka Two-step regulation of Ad4BP/SF-1 gene transcription during fetal adrenal development: initiation by a Hox-Pbx1-Prep1 complex and maintenance via autoregulation by Ad4BP/SF-1 Molecular and Cellular Biology 26 2006 4111 4121
34. D.S. Lala, D.A. Rice, and K.L. Parker Steroidogenic factor I, a key regulator of steroidogenic enzyme expression, is the mouse homolog of fushi tarazu-factor I Molecular Endocrinology 6 1992 1249 1258
35. K. Morohashi, S. Honda, and Y. Inomata A common trans-acting factor, Ad4-binding protein, to the promoters of steroidogenic P-450s The Journal of Biological Chemistry 267 1992 17913 17919
36. T.E. Wilson, T.J. Fahrner, and J. Milbrandt The orphan receptors NGFI-B and steroidogenic factor 1 establish monomer binding as a third paradigm of nuclear receptor-DNA interaction Molecular and Cellular Biology 13 1993 5794 5804
37. I.N. Krylova, E.P. Sablin, and J. Moore Structural analyses reveal phosphatidyl inositols as ligands for the NR5 orphan receptors SF-1 and LRH-1 Cell 120 2005 343 355
38. Y. Li, M. Choi, and G. Cavey Crystallographic identification and functional characterization of phospholipids as ligands for the orphan nuclear receptor steroidogenic factor-1 Molecular Cell 17 2005 491 502
39. W. Wang, C. Zhang, and A. Marimuthu The crystal structures of human steroidogenic factor-1 and liver receptor homologue-1 Proceedings of the National Academy of Sciences of the United States of America 102 2005 7505 7510
40. G.D. Hammer, I. Krylova, and Y. Zhang Phosphorylation of the nuclear receptor SF-1 modulates cofactor recruitment: integration of hormone signaling in reproduction and stress Molecular Cell 3 1999 521 526
41. A.E. Lewis, M. Rusten, and E.A. Hoivik Phosphorylation of steroidogenic factor 1 is mediated by cyclin-dependent kinase 7 Molecular Endocrinology 22 2008 91 104
42. T. Komatsu, H. Mizusaki, and T. Mukai Small ubiquitin-like modifier 1 (SUMO-1) modification of the synergy control motif of Ad4 binding protein/steroidogenic factor 1 (Ad4BP/SF-1) regulates synergistic transcription between Ad4BP/SF-1 and Sox9 Molecular Endocrinology 18 2004 2451 2462
43. W.Y. Chen, W.C. Lee, and N.C. Hsu SUMO modification of repression domains modulates function of nuclear receptor 5A1 (Steroidogenic Factor-1) The Journal of Biological Chemistry 279 2004 38730 38735
44. M.B. Lee, L.A. Lebedeva, and M. Suzawa The DEAD-box protein DP103 (Ddx20 or Gemin-3) represses orphan nuclear receptor activity via SUMO modification Molecular and Cellular Biology 25 2005 1879 1890
45. L.A. Campbell, E.J. Faivre, and M.D. Show Decreased recognition of SUMO-sensitive target genes following modification of SF-1 (NR5A1) Molecular and Cellular Biology 28 2008 7476 7486
46. Y. Ikeda, W.H. Shen, and H.A. Ingraham Developmental expression of mouse Steroidogenic Factor-1, an essential regulator of the steroid hydroxylases Molecular Endocrinology 8 1994 654 662
47. K. Morohashi, H. Tsuboi-Asai, and S. Matsushita Structural and functional abnormalities in the spleen of an mFtz-F1 gene-disrupted mouse Blood 93 1999 1586 1594
48. X. Luo, Y. Ikeda, and K.L. Parker A cell-specific nuclear receptor is essential for adrenal and gonadal development and sexual differentiation Cell 77 1994 481 490
49. Y. Sadovsky, P.A. Crawford, and K.G. Woodson Mice deficient in the orphan receptor steroidogenic factor 1 lack adrenal glands and gonads but express P450 side-chain-cleavage enzyme in the placenta and have normal embryonic serum levels of corticosteroids Proceedings of the National Academy of Sciences of the United States of America 92 1995 10939 10943
50. T. Karpova, J. Presley, and R.R. Manimaran A Ftz-F1-containing yeast artificial chromosome recapitulates expression of steroidogenic factor 1 in vivo Molecular Endocrinology 19 2005 2549 2563
51. Fatchiyah, M. Zubair, and Y. Shima Differential gene dosage effects of Ad4BP/SF-1 on target tissue development Biochemical and Biophysical Research Communications 341 2006 1036 1045
52. M.L. Bland, C.A. Jamieson, and S.F. Akana Haploinsufficiency of steroidogenic factor 1 in mice disrupts adrenal development leading to an impaired stress response Proceedings of the National Academy of Sciences of the United States of America 97 2000 14488 14893
53. D. Wilhelm, and C. Englert The Wilms tumor suppressor WT1 regulates early gonad development by activation of Sf1 Genes & Development 16 2002 1839 1851
54. Y. Shima, M. Zubair, and S. Ishihara Ventromedial hypothalamic nucleus-specific enhancer of Ad4BP/SF-1 gene Molecular Endocrinology 19 2005 2812 2823
55. Y. Shima, M. Zubair, and T. Komatsu Pituitary homeobox 2 regulates adrenal4 binding protein/steroidogenic factor-1 gene transcription in the pituitary gonadotrope through interaction with the intronic enhancer Molecular Endocrinology 22 2008 1633 1646
56. M. Zubair, K.L. Parker, and K. Morohashi Developmental links between the fetal and adult zones of the adrenal cortex revealed by lineage tracing Molecular and Cellular Biology 28 2008 7030 7040
57. J.C. Achermann, M. Ito, and M. Ito A mutation in the gene encoding steroidogenic factor-1 causes XY sex-reversal and adrenal failure in humans Nature Genetics 22 1999 125 126
58. J.L. Jameson Of mice and men: the tale of Steroidogenic Factor-1 The Journal of Clinical Endocrinology and Metabolism 89 2004 5927 5929
59. J.C. Achermann, G. Ozisik, and M. Ito Gonadal determination and adrenal development are regulated by the orphan nuclear receptor Steroidogenic Factor-1, in a dose-dependent manner The Journal of Clinical Endocrinology and Metabolism 87 2002 1829 1833
60. D. Loureno, R. Brauner, and L. Lin Mutations in NR5A1 associated with ovarian insufficiency The New England Journal of Medicine 360 2009 1200 1210
61. A. Biason-Lauber, and E.J. Schoenle Apparently normal ovarian differentiation in a prepubertal girl with transcriptionally inactive steroidogenic factor 1 (NR5A1/SF-1) and adrenocortical insufficiency American Journal of Human Genetics 67 2000 1563 1568
62. L. Lin, and J.C. Achermann Steroidogenic factor-1 (SF-1, Ad4BP, NR5A1) and disorders of testis development Sexual Development 2 2008 200 209
63. E. Zanaria, F. Muscatelli, and B. Bardoni An unusual member of the nuclear hormone receptor superfamily responsible for X-linked adrenal hypoplasia congenita Nature 372 1994 635 641
64. F. Muscatelli, T.M. Strom, and A.P. Walker Mutations in the DAX-1 gene give rise to both X-linked adrenal hypoplasia congenita and hypogonadotropic hypogonadism Nature 372 1994 672 676
65. B. Bardoni, E. Zanaria, and S. Guioli A dosage sensitive locus at chromosome Xp21 is involved in male to female sex reversal Nature Genetics 7 1994 497 501
66. M. Ito, R. Yu, and J.L. Jameson DAX-1 inhibits SF-1-mediated transactivation via a carboxy-terminal domain that is deleted in adrenal hypoplasia congenita Molecular and Cellular Biology 17 1997 1476 1483
67. E. Lalli, B. Bardoni, and E. Zazopoulos A transcriptional silencing domain in DAX-1 whose mutation causes adrenal hypoplasia congenita Molecular Endocrinology 11 1997 1950 1960
68. E.P. Sablin, A. Woods, and I.N. Krylova The structure of corepressor Dax-1 bound to its target nuclear receptor LRH-1 Proceedings of the National Academy of Sciences of the United States of America 105 2008 18390 18395
69. E. Lalli, and P. Sassone-Corsi DAX-1, an unusual orphan receptor at the crossroads of steroidogenic function and sexual differentiation Molecular Endocrinology 17 2003 1445 1453
70. E. Zazopoulos, E. Lalli, and D.M. Stocco DNA binding and transcriptional repression by DAX-1 blocks steroidogenesis Nature 390 1997 311 315
71. E. Lalli, M.H. Melner, and D.M. Stocco DAX-1 blocks steroid production at multiple levels Endocrinology 139 1998 4237 4243
72. S.G. Lehmann, E. Lalli, and P. Sassone-Corsi X-linked adrenal hypoplasia congenita is caused by abnormal nuclear localization of the DAX-1 protein Proceedings of the National Academy of Sciences of the United States of America 99 2002 8225 8230
73. Y. Ikeda, A. Swain, and T.J. Weber Steroidogenic factor 1 and Dax-1 colocalize in multiple cell lineages: potential links in endocrine development Molecular Endocrinology 10 1996 1261 1272
74. R.N. Yu, M. Ito, and T.L. Saunders Role of Ahch in gonadal development and gametogenesis Nature Genetics 20 1998 353 357
75. P.S. Babu, D.L. Bavers, and F. Beuschlein Interaction between Dax-1 and steroidogenic factor-1 in vivo: increased adrenal responsiveness to ACTH in the absence of Dax-1 Endocrinology 143 2002 665 673
76. M.C. Battista, M. Otis, and M. Côté Extracellular matrix and hormones modulate DAX-1 localization in the human fetal adrenal gland The Journal of Clinical Endocrinology and Metabolism 90 2005 5426 5431
77. B.M. Gummow, J.N. Winnay, and G.D. Hammer Convergence of Wnt signaling and steroidogenic factor-1 (SF-1) on transcription of the rat inhibin alpha gene The Journal of Biological Chemistry 278 2003 26572 26579
78. O.A. Botrugno, E. Fayard, and J.S. Annicotte Synergy between LRH-1 and beta-catenin induces G1 cyclin-mediated cell proliferation Molecular Cell 15 2004 499 509
79. A.C. Kim, A.L. Reuter, and M. Zubair Targeted disruption of beta-catenin in Sf1-expressing cells impairs development and maintenance of the adrenal cortex Development 135 2008 2593 2602
80. F. Tissier, C. Cavard, and L. Groussin Mutations of beta-catenin in adrenocortical tumors: activation of the Wnt signaling pathway is a frequent event in both benign and malignant adrenocortical tumors Cancer Research 65 2005 7622 7627
81. M. Doghman, J. Cazareth, and E. Lalli The T cell factor/beta-catenin antagonist PKF115-584 inhibits proliferation of adrenocortical carcinoma cells The Journal of Clinical Endocrinology and Metabolism 93 2008 3222 3225
82. M. Varjosalo, and J. Taipale Hedgehog: functions and mechanisms Genes & Development 22 2008 2454 2472
83. C. Dubourg, C. Bendavid, and L. Pasquier Holoprosencephaly Orphanet Journal of Rare Diseases 2 2007 8
84. S. Kang, J.M. Graham Jr., and A.H. Olney GLI3 frameshift mutations cause autosomal dominant Pallister-Hall syndrome Nature Genetics 15 1997 266 268 (Pubitemid 27098719)
85. J. Böse, L. Grotewold, and U. Rüther Pallister-Hall syndrome phenotype in mice mutant for Gli3 Human Molecular Genetics 11 2002 1129 1135
86. S. Ching, and E. Vilain Targeted disruption of Sonic Hedgehog in the mouse adrenal leads to adrenocortical hypoplasia Genesis 47 2009 628 637
87. E. Vilain, M. Le Merrer, and C. Lecointre IMAGe, a new clinical association of intrauterine growth retardation, metaphyseal dysplasia, adrenal hypoplasia congenita, and genital anomalies The Journal of Clinical Endocrinology and Metabolism 84 1999 4335 4340
88. T.Y. Tan, J.L. Jameson, and P.E. Campbell Two sisters with IMAGe syndrome: cytomegalic adrenal histopathology, support for autosomal recessive inheritance and literature review American Journal of Medical Genetics. Part A 140 2006 1778 1784
89. J.E. Hutz, A.S. Krause, and J.C. Achermann IMAGe association and congenital adrenal hypoplasia: no disease-causing mutations found in the ACD gene Molecular Genetics and Metabolism 88 2006 66 70
90. C.E. Keegan, J.E. Hutz, and T. Else Urogenital and caudal dysgenesis in adrenocortical dysplasia (acd) mice is caused by a splicing mutation in a novel telomeric regulator Human Molecular Genetics 14 2005 113 123
91. T. Else, A. Trovato, and A.C. Kim Genetic p53 deficiency partially rescues the adrenocortical dysplasia phenotype at the expense of increased tumorigenesis Cancer Cell 15 2009 465 476
92. J.M. Cronshaw, and M.J. Matunis The nuclear pore complex protein ALADIN is mislocalized in triple A syndrome Proceedings of the National Academy of Sciences of the United States of America 100 2003 5823 5827
93. M. Hirano, Y. Furiya, and H. Asai ALADINI482S causes selective failure of nuclear protein import and hypersensitivity to oxidative stress in triple A syndrome Proceedings of the National Academy of Sciences of the United States of America 103 2006 2298 2303
94. A.P. Coll, B.G. Challis, and G.S. Yeo The effects of proopiomelanocortin deficiency on murine adrenal development and responsiveness to adrenocorticotropin Endocrinology 145 2004 4721 4727
95. A.B. Bicknell, K. Lomthaisong, and R.J. Woods Characterization of a serine protease that cleaves pro-gamma-melanotropin at the adrenal to stimulate growth Cell 105 2001 903 912
96. H. Krude, H. Biebermann, and W. Luck Severe early-onset obesity, adrenal insufficiency and red hair pigmentation caused by POMC mutations in humans Nature Genetics 19 1998 155 157
97. R.S. Jackson, J.W. Creemers, and S. Ohagi Obesity and impaired prohormone processing associated with mutations in the human prohormone convertase 1 gene Nature Genetics 16 1997 303 306
98. B. Lamolet, A.M. Pulichino, and T. Lamonerie A pituitary cell-restricted T box factor, Tpit, activates POMC transcription in cooperation with Pitx homeoproteins Cell 104 2001 849 859
99. A.J. Clark, L.F. Chan, and T.T. Chung The genetics of familial glucocorticoid deficiency Best Practice & Research. Clinical Endocrinology & Metabolism 23 2009 159 165
100. M. Doghman, T. Karpova, and G.A. Rodrigues Increased steroidogenic factor-1 dosage triggers adrenocortical cell proliferation and cancer Molecular Endocrinology 21 2007 2968 2987